#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IgA nephropathy Neuroendocrine carcinoma of the skin Alagille syndrome Mucous membrane pemphigoid Henoch-Schonlein purpura nephritis Solitary fibrous tumour Aspergillus infection Stiff person syndrome Von Hippel-Lindau disease Oesophageal squamous cell carcinoma stage III Multiple system atrophy Eosinophilic granulomatosis with polyangiitis Hodgkin's disease Congenital nephrogenic diabetes insipidus Scedosporium infection More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Treatment Pulmonary fibrosis – Diagnostics Cystic fibrosis Richter’s syndrome – Treatment Ocular melanoma – Life with Disease Haemophilia A without inhibitors – Treatment Usher’s syndrome Prader-Willi syndrome – Life with Disease Phenylketonuria – Life with Disease IgA nephropathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunostimulants Zelicapavir Corylus Avellana L. GSKVX000000070965 Ro7247669 Dabigatran Etexilate Indacaterol Acetate ANTIMETABOLITES Elezanumab Nemvaleukin Alfa Berzosertib Tin816 Estradiol Verapamil Aripiprazole Dextran 70 Octocog Alfa Imlifidase Ro7790121 Codeine Phosphate Hemihydrate More therapies…

    Learn about Your Condition

    Gastric cancer recurrent Procedural headache Obesity Urticaria cholinergic Subdural haematoma Cervix carcinoma recurrent Tachypnoea Extraskeletal ossification Thrombosis prophylaxis Uterine cancer Meningococcal infection Urinary incontinence Malignant melanoma stage II Anorexia nervosa Acute on chronic liver failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. ZDRAVSTVENI DOM Osnovno varstvo Nova Gorica

ZDRAVSTVENI DOM Osnovno varstvo Nova Gorica

Rejceva Ulica 4, Nova Gorica, 5000, Slovenia

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin
    • Dapagliflozin
    • Cagrilintide
    Bulgaria Croatia Czechia Denmark Finland Germany +9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!